3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
10
Carcinoma, Non-Small-Cell Lung
6
Neoplasm Metastasis
4
Thyroid Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Colorectal Neoplasms
3
Triple Negative Breast Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Hairy Cell
2
Hematologic Neoplasms
2
Glioma
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Diseases
1
Stomach Neoplasms
1
Solid Tumors
1
Skin Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Neurofibromatosis 1
1
Neoplasms
1
Lymphatic Metastasis
1
Klatskin Tumor
1
Interventions
Temozolomide
40
Magnetic Resonance Spectroscopy
19
Radiotherapy
18
Specimen Handling
14
Radiation
12
Bevacizumab
11
Lomustine
9
pembrolizumab
6
fludarabine
5
Surgical Procedures, Operative
5
atezolizumab
4
Nivolumab
4
Ipilimumab
4
Cyclophosphamide
4
Carboplatin
4
Biopsy
4
cemiplimab
3
azeliragon
3
Immunoglobulin G
3
Disulfides
3
Aminolevulinic Acid
3
veliparib
2
trametinib
2
rocakinogene sifuplasmid
2
poly ICLC
2
olaparib
2
lutetium Lu 177 dotatate
2
durvalumab
2
dabrafenib
2
contrast agent BR1
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
binimetinib
×
90 days
×
Clear all
No trials found.